Do Physicians/Researchers Trade Stock Based on Privileged Information? A Closer Look at Trading Patterns Surrounding the Annual ASCO Conference

Author:

Mark Elie Donath,Eisenberg J.

Abstract

There is a concern that physicians/researchers are inappropriately profiting (by buying or selling stock) from information derived from advance copies of high-impact clinical trial data distributed by medical conferences or journals. Despite these concerns, it has never been systematically evaluated, and little is known about the degree to which it exists. This is largely due to difficulties associated with directly verifying whether or not such activities have taken place and, furthermore, many medical conferences/journals today have taken the necessary actions to guard against this. One medical association in particular, the American Society of Clinical Oncology (ASCO responsible for conducting the largest annual oncology-related medical conference), only began responding to such concerns several years ago. Their actions during that time serve as a compelling case study, with wide-ranging ramifications, and provide the unique opportunity to delve into this phenomenon.Up until 2008, ASCO selectively and discreetly distributed abstracts from all forthcoming presentations (at the ASCO Conference) to ASCO members two weeks prior to it becoming publicly accessible during the conference.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy,General Medicine,Issues, ethics and legal aspects

Reference7 articles.

1. 2 Arnst, C. , “How Drug News Leaks to Investors,” BusinessWeek Magazine, May 6, 2002, available at (last visited April 6, 2012).

2. “The Clinical Trial Participant as an Insider Trader: A Legal and Policy Analysis,”;Horwich;Journal of Health Law,2006

3. 4 Pharmboy, A. , "ASCO Abstracts Trigger Trading," Terra Sig Online, May 19, 2007, available at (last visited April 6, 2012)

4. Cortez, M. Randall, T. , "What Cancer Doctors Know Kills ASCO's Book for Insider Trading," Bloomberg: Health Care, May 14, 2008, available at

5. Lowe, D. , "Is There Any Insider Trading Going On in Drug Stocks," Seeking Alpha, December 15, 2008, available at (last visited April 6, 2012).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3